{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:24:57Z","timestamp":1785860697060,"version":"3.56.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1097\/01.hpc.0000131548.11420.86","type":"journal-article","created":{"date-parts":[[2004,5,28]],"date-time":"2004-05-28T04:00:37Z","timestamp":1085716837000},"page":"95-100","source":"Crossref","is-referenced-by-count":0,"title":["Greater Benefit of Early Invasive Strategy for Unstable Angina and Non-ST Elevation Myocardial Infarction in United States Compared With Non-United States Patients"],"prefix":"10.1097","volume":"3","author":[{"given":"Howard C.","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Dibattiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Delucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Demopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210119","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban.","volume":"344","author":"Cannon","year":"2001","journal-title":"New Engl J Med"},{"key":"R2-9-20210119","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-9-20210119","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes.","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"R4-9-20210119","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial.","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"R5-9-20210119","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9149(98)00540-2","article-title":"Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial.","volume":"82","author":"Cannon","year":"1998","journal-title":"Am J Cardiol"},{"key":"R6-9-20210119","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making.","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"R7-9-20210119","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.CIR.89.4.1545","article-title":"Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction.","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"R8-9-20210119","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","article-title":"Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive vs compared with a conservative management strategy.","volume":"338","author":"Boden","year":"1998","journal-title":"N Engl J Med"},{"key":"R9-9-20210119","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary disease: FRISC II prospective randomized multicenter study.","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"R10-9-20210119","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJM200106213442510","article-title":"Optimal treatment of acute coronary syndrome - an evolving strategy.","volume":"344","author":"Boden","year":"2001","journal-title":"N Engl J Med"},{"issue":"suppl V","key":"R11-9-20210119","first-page":"V1","article-title":"Management of patients with non-ST segment elevation acute coronary syndromes: insights from the PURSUIT trial.","volume":"23","author":"Fintel","year":"2000","journal-title":"Clin Cardio"},{"key":"R12-9-20210119","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction.","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"R13-9-20210119","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/jama.284.7.876","article-title":"Risk stratification and therapeutic decision making in acute coronary syndromes.","volume":"284","author":"Ohman","year":"2000","journal-title":"JAMA"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00132577-200406000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:31:02Z","timestamp":1785857462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00132577-200406000-00009"}},"subtitle":["A TACTICS-TIMI 18 Substudy"],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.hpc.0000131548.11420.86","relation":{},"ISSN":["1535-282X"],"issn-type":[{"value":"1535-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}